CVS Health Co. (NYSE:CVS) Stock Holdings Increased by Man Group plc

Man Group plc grew its stake in CVS Health Co. (NYSE:CVS - Free Report) by 230.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 840,814 shares of the pharmacy operator's stock after acquiring an additional 586,270 shares during the quarter. Man Group plc owned about 0.07% of CVS Health worth $37,744,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Coppell Advisory Solutions LLC lifted its position in CVS Health by 17.3% during the fourth quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock worth $56,000 after buying an additional 189 shares during the period. EagleClaw Capital Managment LLC lifted its position in CVS Health by 3.4% during the fourth quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock worth $275,000 after buying an additional 200 shares during the period. Manchester Capital Management LLC lifted its position in CVS Health by 4.8% during the fourth quarter. Manchester Capital Management LLC now owns 4,457 shares of the pharmacy operator's stock worth $200,000 after buying an additional 204 shares during the period. Angeles Investment Advisors LLC lifted its position in CVS Health by 3.7% during the fourth quarter. Angeles Investment Advisors LLC now owns 5,706 shares of the pharmacy operator's stock worth $256,000 after buying an additional 204 shares during the period. Finally, Rogco LP lifted its position in CVS Health by 3.2% during the fourth quarter. Rogco LP now owns 6,752 shares of the pharmacy operator's stock worth $303,000 after buying an additional 210 shares during the period. 80.66% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

CVS has been the topic of several recent analyst reports. Edward Jones upgraded CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. UBS Group lifted their price objective on CVS Health from $67.00 to $71.00 and gave the company a "neutral" rating in a research note on Friday, May 2nd. Royal Bank of Canada lifted their price objective on CVS Health from $74.00 to $81.00 and gave the company an "outperform" rating in a research note on Monday, May 5th. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a research note on Wednesday, February 12th. Finally, JPMorgan Chase & Co. lifted their price objective on CVS Health from $80.00 to $81.00 and gave the company an "overweight" rating in a research note on Tuesday, February 18th. Three analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $74.94.

Insider Transactions at CVS Health

In related news, Director Michael F. Mahoney purchased 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were acquired at an average price of $66.70 per share, with a total value of $2,001,000.00. Following the acquisition, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. This trade represents a 320.65% increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the firm's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at approximately $556,941.90. This trade represents a 47.23% decrease in their position. The disclosure for this sale can be found here. Insiders own 1.22% of the company's stock.

CVS Health Stock Up 3.4%

NYSE CVS traded up $2.04 during mid-day trading on Friday, reaching $62.51. 10,777,559 shares of the company's stock traded hands, compared to its average volume of 11,442,534. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $72.51. The company has a fifty day simple moving average of $66.57 and a 200-day simple moving average of $59.22. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The company has a market cap of $79.07 billion, a price-to-earnings ratio of 17.08, a P/E/G ratio of 0.98 and a beta of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. During the same quarter last year, the firm earned $1.31 EPS. CVS Health's quarterly revenue was up 7.0% on a year-over-year basis. As a group, equities research analysts expect that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd were given a $0.665 dividend. The ex-dividend date was Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 4.26%. CVS Health's payout ratio is 63.48%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.